Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Cartesian Therapeutics, Inc. (RNAC) had Return on Investments of -21.79% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$13.72M |
|
-- |
|
-- |
|
$29.16M |
|
$-29.16M |
|
$44.92M |
|
$15.77M |
|
$15.77M |
|
$15.77M |
|
$15.77M |
|
$15.77M |
|
$15.77M |
|
$-29.16M |
|
$-28.38M |
|
29.47M |
|
29.86M |
|
$0.47 |
|
$0.46 |
|
| Balance Sheet Financials | |
$153.62M |
|
$11.31M |
|
$165.01M |
|
$318.63M |
|
$20.55M |
|
$52.85M |
|
$423.30M |
|
$443.85M |
|
$-125.23M |
|
$-173.39M |
|
$-125.23M |
|
30.04M |
|
| Cash Flow Statement Financials | |
$-43.22M |
|
$-0.30M |
|
$66.02M |
|
$126.87M |
|
$149.34M |
|
$22.47M |
|
$4.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.48 |
|
-- |
|
-- |
|
-0.73 |
|
-0.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-43.52M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.59% |
|
-9.09% |
|
4.95% |
|
|
Return on Investments |
-21.79% |
$-4.17 |
|
$-1.46 |
|
$-1.45 |
|